Navigation Links
NJIT doctoral students receive recognition at poster competition
Date:5/14/2008

Giuseppe Di Benedetto and Micaela Caramellino, two doctoral students in NJITs graduate chemical engineering program, recently received recognition at a student poster event organized for developing efficient and robust approaches to manufacture nano- and micro-sized drug particles. The New Jersey section of the International Society for Pharmaceutical Engineering was the sponsor.

In recent years, the pharmaceutical industry has recognized that new technologies and methods must be developed to design, optimize, scale-up, and control processes involved in the manufacture of drug products, said Piero Armenante, PhD, research advisor of both students and director of NJITs pharmaceutical engineering program. One promising area of technological research is the development of novel methods to manufacture nano- and micro-size drug particles. Such small particles offer the advantage of being more rapidly and efficiently taken up by the body because of their smaller size and increased surface area.

Di Benedetto, who grew up in Newark, but now lives in Little Falls, received the highest score of all participants by demonstrating how the equipment that he assembled, comprising pumps, small-scale reactors, tanks and other laboratory equipment, could make two small liquid streams collide, producing nano and micro-sized particles. Prior to this competition Di Benedetto has presented his results at two sessions of the November 2007 meeting of the American Institute of Chemical Engineering (AIChE). His work was also presented at the 2007 Biennial North American Mixing Forum Conference.

Caramellino of Nutley presented her research project, in which she explained how she used a high shear device to fragment micro particles. Her research was also presented last November at the AIChE meeting.

Next fall, both students will travel to Boca Raton, all expenses paid, to compete in ISPEs larger national competition. Grants from the Engineerin
'/>"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Opportunity for students displaced by Katrina to assess climate vulnerability of Southeast US
2. University of Minnesota releases first ever comprehensive report of the health of college students
3. Carnegie Mellon students win contest
4. Where college students live can impact their weight, eating and exercise habits
5. NJIT applauds students for studies on brain injury, glaucoma and more
6. Rutgers Genetics receives $7.8 million for autism research
7. Herr receives Heinz Award for Technology, the Economy and Employment
8. UCI receives $5M from Edwards Lifesciences
9. Yu receives research funding from the Wallace H. Coulter Foundation
10. UGA Odum School of Ecology professor receives grant to study West Nile Virus in NYC
11. UC Riverside biologist receives prestigious MacArthur Fellowship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... German . ... refraction of X-rays through a specimen instead of attenuation ... are often of much higher quality than those based ... Franz Pfeiffer are particularly interested in developing new approaches ... phase-contrast imaging. One main goal is to make this ...
(Date:7/11/2014)... National Institute of Standards and Technology (NIST) need ... effectively, they often prove that necessity is truly ... recently for M. Lorna De Leoz and Stephen ... of glycomics. Glycomics is the study of the ... attached to proteins and lipids and influence cellular ...
(Date:7/11/2014)... China Researchers from Salk Institute for Biological Studies, ... evaluated the safety and reliability of the existing ... new method, TALEN-HDAdV, which could significantly increased gene-correction ... This study published online in Cell Stell ... stem cell-based gene therapy. , The combination of ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2A new genome editing method brings the possibility of gene therapies closer to reality 2
... target for a drug seems very promising on paper; ... of telomerase inhibitors,to treat cancer; they are supposed to ... cells. Yet, something in the cell,seems to block their ... do then? Scrap the project? Look for something,else? Hell ...
... in humans in forests between Gabon and the Republic ... animal carcasses, according to a study by the Wildlife ... the February edition of the journal Emerging Infectious Diseases, ... Ebola between 2001 and 2003 produced positive results, and ...
... by human activity and the extinction of species around ... warns a Canadian zoologist. This ecological damage also endangers ... , Dr. Daniel (Dan) Brooks, a parasitologist at the ... is linked to the emergence of new human and ...
Cached Biology News:Combination therapy boosts effectiveness of telomere-directed cancer cell death 2Study Links Ebola Outbreaks To Animal Carcasses 2Ecological destruction fuels emerging diseases 2
(Date:7/10/2014)... July 10, 2014 Product and ... very low abundance and are often “lost in ... time-consuming. , Join presenters Dr. Rowel Tobias, Senior ... John Anders, Head of Quality at Nanotherapeutics, Inc., ... that can speed detection and quantitation while achieving ...
(Date:7/10/2014)... Understanding the need for better quality and higher ... that currently exists in this area, ChanTest has recently ... validated ion channel and GPCR cell lines. ChanTest’s ... channels control many critical physiological functions throughout the body. ... to treat a variety of human diseases. , ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 Unraveling ... closer together. The Archer Family purchased a ... within DNA, but ended up with a lifetime of ... contained within the family members’ DNA genuinely brought the ... decided to search deeper into genetic history and prior ...
(Date:7/10/2014)... 10, 2014 OMICS Group’s 5th International ... 18-20 August, 2014 at Double Tree by Hilton Beijing, ... developments in Analytical & Bioanalytical research methods only to ... on this occasion, Dr. Srinubabu Gedela, MD of OMICS ... is a remarkable one in bringing a unique and ...
Breaking Biology Technology:Novel Ms Techniques Speed Detection of Biopharmaceutical Product and Process Impurities, New Webinar Hosted by Xtalks 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4
... MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, ... and bioimplants processed from human amniotic membrane, announced ... Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders ... Petit, Chairman and CEO, William C. Taylor, President ...
... and TORONTO, Dec. 1, 2011 Generex Biotechnology Corporation ... on the status of the clinical and regulatory ... insulin spray product. Work has been ... analyses), and revising all of the extant Generex ...
... Calif., Dec. 1, 2011  VIVUS, Inc. (NASDAQ: VVUS ... present an overview of the company at the 2011 Deutsche ... place at the Four Seasons Hotel, Boston, MA on Tuesday, ... and 30-day archive of the presentation will be available at ...
Cached Biology Technology:Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program 2Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program 3Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program 4VIVUS to Present at the Deutsche Bank BioFEST Conference 2VIVUS to Present at the Deutsche Bank BioFEST Conference 3
Mouse monoclonal [6911] to E. coli K99 pilus ( Abpromise for all tested applications)....
...
... genetically encoded fluorescent sensor capable for high ... one of the main ROS generated by ... fluorescent protein inserted into the regulatory domain ... demonstrates submicromolar affinity to H2O2 and at ...
Alexa Fluor 647 anti-mouse Qa-2...
Biology Products: